Internet Security Services Company AVG Technologies Outlook Revised To Positive Following IPO; 'B+' Rating Affirmed Mar 12

  • ID: 2083367
  • March 2012
  • Standard & Poors
1 of 3

Czech Internet security services provider AVG Technologies N.V. (AVG) recently completed an IPO, which we believe has improved its capital structure. In addition, fast-growing revenues in the company's platform division are driving a continued improvement in operating performance. We are therefore revising our outlook on AVG to positive from stable and affirming our 'B+' long-term corporate credit and issue ratings on the company. The positive outlook reflects the possibility that we could raise our long-term rating on AVG by one notch over the next 12 months if the company continues to improve its operating performance while maintaining limited leverage. LONDON (Standard & Poor's) March 5, 2012--Standard & Poor's Ratings Services said today that it revised its outlook on Czech Republic-based...

Companies mentioned in this report are: AVG Technologies N.V.
Action: Affirmed
Action: Outlook: Positive

Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, insurance companies, utilities, sovereigns and structured finance programs. RatingsXpress Credit Research lets users determine the credit rating of holdings and identify key factors underlying an issuer's creditworthiness, distinguishes the different risk exposures for new and existing deals, and provides an understanding of how their analysts interpret key regulatory, political and environmental events and their economic impact.

Research type: News
This product is a is a brief one-page announcement of no more than 500 words with a quote from the analyst. It is media and investor focused with no accompanying commentary article.

Note: Product cover images may vary from those shown
2 of 3

AVG Technologies N.V.

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown





Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer Inc.